Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Curanex Pharmaceuticals Q3 2026 Results: Net Loss of $2.82M, Loss Widens

Curanex Pharmaceuticals Inc reported a net loss of $9.26 million for the nine months ended September 30, 2026, a significant increase from the $1.15 million loss in the prior year period, primarily driven by a surge in Research & Development expenses. The company's cash position decreased to $1.58 million from $4.97 million at the start of the year, reflecting ongoing operational burn as it develops botanical drugs for inflammatory diseases.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-2.8-1.0
EPS (diluted, $ a share)$-1.86$-0.75

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: CURX. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Curanex Pharmaceuticals Inc: key numbers

Share price
$4.70Close, Nov 17
Market cap
$7.37M
Shares outstanding
1.57MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Curanex Pharmaceuticals Inc

All →
5:15 PM ET 8-K
Court & Legal Update

Curanex Pharmaceuticals Court & Legal Update

Curanex Pharmaceuticals disclosed two putative securities class action lawsuits filed in the Supreme Court of the State of New York related to its August 2025 IPO. The complaints allege material misstatements and omissions in the IPO offering documents regarding risks of stock-price manipulation and underwriter due diligence deficiencies. The company intends to defend the actions vigorously and has received extensions to respond to the complaints through late 2026.

Counterparty
Daymond Morales and Robert Lovett

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.